Zoran Zdraveski
2023
In 2023, Zoran Zdraveski earned a total compensation of $1.6M as Chief Legal and Strategy Officer and Secretary at TScan Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $203,000 |
|---|---|
| Option Awards | $924,566 |
| Salary | $441,000 |
| Other | $13,200 |
| Total | $1,581,766 |
Zdraveski received $924.6K in option awards, accounting for 58% of the total pay in 2023.
Zdraveski also received $203K in non-equity incentive plan, $441K in salary and $13.2K in other compensation.
Rankings
In 2023, Zoran Zdraveski's compensation ranked 739th out of 2,918 executives tracked by ExecPay. In other words, Zdraveski earned more than 74.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 739 out of 2,918 | 75th |
Division Manufacturing | 426 out of 1,608 | 74th |
Major group Chemicals And Allied Products | 290 out of 901 | 68th |
Industry group Drugs | 284 out of 864 | 67th |
Industry Biological Products, Except Diagnostic Substances | 91 out of 211 | 57th |
Source: SEC filing on April 30, 2024.
Zdraveski's colleagues
We found four more compensation records of executives who worked with Zoran Zdraveski at TScan Therapeutics in 2023.